ENANTA PHARMACEUTICALS INC (ENTA)
Sector: Health Care
Named Executive Officers
Compensation data for top executives (showing up to 3 years of data)
| Executive | Year | Salary | Bonus | Stock Awards | Option Awards | Non-Equity Incentive Comp | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| Jay R. Luly, Ph.D. President and Chief Executive Officer | 2025 | $803,300 | $N/A | $128,550 | $1,223,975 | $591,665 | $22,058 | $2,769,548 |
| 2024 | $779,875 | $0 | $166,367 | $1,297,481 | $429,455 | $22,098 | $2,695,276 | |
| 2023 | $755,375 | $0 | $3,520,440 | $3,084,399 | $475,886 | $20,598 | $7,856,698 |
| Executive | Year | Salary | Bonus | Stock Awards | Option Awards | Non-Equity Incentive Comp | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| Scott T. Rottinghaus, M.D. Chief Medical Officer | 2025 | $560,300 | $N/A | $53,563 | $425,943 | $281,348 | $22,058 | $1,343,212 |
| 2024 | $544,000 | $0 | $58,272 | $422,664 | $210,040 | $22,098 | $1,257,074 | |
| 2023 | $530,250 | $0 | $577,080 | $345,269 | $190,678 | $11,448 | $1,654,724 |
| Executive | Year | Salary | Bonus | Stock Awards | Option Awards | Non-Equity Incentive Comp | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| Yat Sun Or, Ph.D. Chief Scientific Officer | 2025 | $553,150 | $N/A | $53,563 | $425,943 | $239,374 | $21,761 | $1,293,790 |
| 2024 | $537,050 | $0 | $59,933 | $422,664 | $181,166 | $21,892 | $1,222,705 | |
| 2023 | $501,250 | $0 | $764,324 | $985,114 | $199,695 | $19,218 | $2,469,600 |